Physician Assistant in Mountain Home, AR Accepting Medicare

6 Physician Assistant nurses found. Showing 1 - 6

Mrs. Hillary-paige Graves Potter, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 17 Medical Plz, Mountain Home, AR 72653 Phone: 870-508-5900

Jeffery D Tate, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 555 W 6th St, Mountain Home, AR 72653 Phone: 870-425-8288    Fax: 870-425-8299

James C Roelke, P.A. Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 628 Hospital Dr, Ground Floor, Suite A, Mountain Home, AR 72653 Phone: 870-425-4402    Fax: 870-424-3089

Mrs. Kelly Marie Krause, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2062 Highway 62 W, Mountain Home, AR 72653 Phone: 870-425-5464    Fax: 870-425-5465

Niger Stice, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 17 Medical Plaza, Mountain Home, AR 72653 Phone: 870-425-6235    Fax: 870-424-3774

Mrs. Diana Sue Riley, P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 628 Hospital Dr, Suite G-c, Mountain Home, AR 72653 Phone: 870-508-5010    Fax: 870-508-5020

News Archive

New insights into participation of underrepresented communities in Alzheimer's clinical trials

A significant hurdle in developing therapeutics and care models for Alzheimer's disease that work for people of all ethnic and racial backgrounds is the recruitment and retention of traditionally underrepresented groups in clinical trials.

Penn researchers use mathematical modeling to better understand mechanisms in TBI

Even the mildest form of a traumatic brain injury, better known as a concussion, can deal permanent, irreparable damage. Now, an interdisciplinary team of researchers at the University of Pennsylvania is using mathematical modeling to better understand the mechanisms at play in this kind of injury, with an eye toward protecting the brain from its long-term consequences.

First patient dosed in long term-safety extension study of Resolaris for adult patients with FSHD

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, today announced that the first patient has been dosed in a newly initiated long term-safety extension study of Resolaris for adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare and severe genetic myopathy for which there are currently no approved treatments.

Iroko announces results from diclofenac Phase 3 study on post-surgical pain

Iroko Pharmaceuticals, LLC today announced Phase 3 study results that showed patients treated with the company's novel, submicron particle, lower-dose diclofenac (18mg and 35mg), a non-steroidal anti-inflammatory drug (NSAID), experienced significant pain relief post surgery compared with placebo>0.01 and P<0.001 respectively).

Read more Medical News

› Verified 8 days ago